Ruilong Lan
Impact in
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid
- Acute Kidney Injury Research
-
- Cancer-related molecular mechanisms research
Papers in
-
- Circular RNAs in diseases 3
- Cancer-related gene regulation 3
- Wnt/β-catenin signaling in development and cancer 2
- Oncology 12
- Cancer Cells and Metastasis 5
- Co-authors
- Fei Huang (14 shared papers)Junying Chen (12 shared papers)Yanfang Xu (3 shared papers)Lurong Zhang (9 shared papers)Kunmei Lai (3 shared papers)Jianhua Lin (9 shared papers)Jinsheng Hong (10 shared papers)Zhimin Chen (2 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (2 papers)Oncology Reports (2 papers)Cell Death Discovery (1 paper)Cell Death and Disease (1 paper)Frontiers in Bioengineering and Biotechnology (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Ruilong Lan
30 papers receiving 508 citations
Peers
Comparison fields: 5 of 94
- Nephrology 68
- Cancer Research 74
- Immunology 98
- Pharmacology 40
- Molecular Biology 251
Countries citing papers authored by Ruilong Lan
This map shows the geographic impact of Ruilong Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruilong Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruilong Lan more than expected).
Fields of papers citing papers by Ruilong Lan
This network shows the impact of papers produced by Ruilong Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruilong Lan. The network helps show where Ruilong Lan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruilong Lan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 139 | |
| 2 | 2014 | 55 | |
| 3 | 2018 | 38 | |
| 4 | 2023 | 30 | |
| 5 | 2020 | 29 | |
| 6 | 2022 | 25 | |
| 7 | 2017 | 23 | |
| 8 | 2020 | 16 | |
| 9 | 2015 | 14 | |
| 10 | 2021 | 14 | |
| 11 | Vitronectin significantly influences prognosis in osteosarcoma. | 2015 | 14 |
| 12 | 2018 | 13 | |
| 13 | 2017 | 13 | |
| 14 | 2021 | 12 | |
| 15 | 2017 | 11 | |
| 16 | 2018 | 10 | |
| 17 | 2023 | 8 | |
| 18 | 2022 | 8 | |
| 19 | 2016 | 7 | |
| 20 | 2018 | 7 |
About Ruilong Lan
Ruilong Lan is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Nephrology, having authored 31 papers that have together received 512 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (5 papers), Immune Cell Function and Interaction (4 papers), Immunotherapy and Immune Responses (4 papers), Circular RNAs in diseases (3 papers), Cancer-related gene regulation (3 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Molecular Junctions and Nanostructures (2 papers) and Effects of Radiation Exposure (2 papers). The work is most often cited by research in Nephrology (68 citations), Cancer Research (74 citations), Immunology (98 citations), Pharmacology (40 citations) and Molecular Biology (251 citations). Ruilong Lan has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Fei Huang, Junying Chen, Yanfang Xu, Lurong Zhang, Kunmei Lai, Jianhua Lin, Jinsheng Hong, Zhimin Chen, Ruiqing Chen and Yinshuang Li. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Oncology Reports, Cell Death Discovery, Cell Death and Disease and Frontiers in Bioengineering and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.